DeSanctis–Cacchione syndrome
(Redirected from De Sanctis-Cacchione syndrome)
DeSanctis–Cacchione syndrome is a rare genetic disorder characterized by a combination of xeroderma pigmentosum (XP) and neurological abnormalities. This syndrome is named after the Italian physicians who first described it, DeSanctis and Cacchione.
Clinical Features[edit | edit source]
Individuals with DeSanctis–Cacchione syndrome exhibit symptoms of xeroderma pigmentosum, which include extreme sensitivity to ultraviolet (UV) radiation, leading to a high risk of skin cancer. In addition to the dermatological manifestations, patients also present with a range of neurological abnormalities such as intellectual disability, microcephaly, ataxia, and spasticity.
Genetics[edit | edit source]
DeSanctis–Cacchione syndrome is inherited in an autosomal recessive manner. Mutations in genes responsible for nucleotide excision repair (NER) are implicated in the pathogenesis of this syndrome. These genes are crucial for repairing DNA damage caused by UV radiation.
Diagnosis[edit | edit source]
The diagnosis of DeSanctis–Cacchione syndrome is based on clinical evaluation, family history, and genetic testing. Skin biopsy and fibroblast cultures can be used to assess the DNA repair capacity of cells. Genetic testing can identify mutations in the NER pathway genes.
Management[edit | edit source]
There is no cure for DeSanctis–Cacchione syndrome. Management focuses on protecting the skin from UV radiation, regular dermatological examinations to monitor for skin cancer, and supportive care for neurological symptoms. Patients are advised to avoid sun exposure and use protective clothing and sunscreen.
Prognosis[edit | edit source]
The prognosis for individuals with DeSanctis–Cacchione syndrome varies depending on the severity of the neurological and dermatological symptoms. Early diagnosis and rigorous protection from UV radiation can improve the quality of life and reduce the risk of skin cancer.
Related Pages[edit | edit source]
- Xeroderma pigmentosum
- Nucleotide excision repair
- Autosomal recessive
- Intellectual disability
- Microcephaly
- Ataxia
- Spasticity
References[edit | edit source]
External Links[edit | edit source]
-
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD